Ceapro Inc.
Industry
- Pharmaceuticals
- Vaccines
- OTC, Consumer
- Biotechnology
- Drug Discovery Technologies
- Molecular Diversity
- Natural Products
- Molecular Diversity
- Drug Discovery Technologies
Latest on Ceapro Inc.
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Organon Will Market Lilly’s Emgality, R
Erasca Five-Year Collaboration With MD Anderson Focused On MAPKlamp Combo Precision oncology-focused Erasca, Inc. inked a research and development collaboration on 23 August with the University of
New At The Helm Company Changes ALLSOP , David To: Amicus Therapeutics Inc. , SVP, International (April) From: Biogen Idec, SVP, Europe & Canada Phone: 609-662-2000 ATHA , Cindy To: Atossa
Company Changes ABATE , Gerard, MD To: Atherotech Diagnostics Lab , Chief Clinical Officer, (September) From: Daiichi Sankyo Co. Ltd., Senior Medical Dir., Medical Affairs, Thrombosis Phone: 80